HERON THERAPEUTICS, INC. /DE/ (HRTX) Financial Statements
HERON THERAPEUTICS, INC. /DE/ (HRTX) files with the U.S. Securities and Exchange Commission under CIK 0000818033. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- $154.90 million
- Net Income
- -$20.20 million
- Total Assets
- $255.88 million
- Net Cash from Operations
- -$27.59 million
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 10, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for HRTX in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History